Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Janssen Sciences Ireland UC .
Filed returns
46
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Government on J&J's economic contribution to Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Taoiseach Micheál Martin (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagements with Irish policymakers on national life sciences policy (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Minister Hildegarde Naughton (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Meeting with Billy Kelleher MEP on the Critical Medicines Act (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Meeting with Minister of State Thomas Byrne (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with the Taoiseach (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Meeting with Minister Peter Burke (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with the Tánaiste (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Meeting with Minister Thomas Byrne on EU Presidency priorities (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Interactions with Fianna Fáil on the life sciences sector and patient access to new medicines (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Interactions with MEPs on EU and national life sciences policy (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Introductions to new Ministers outlining industry priorities (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Interaction with Secretary General of the Department of Health (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Communication with DETE on national strategy for the life sciences sector (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Courtesy call with an Taoiseach (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Communication with MEPs on outlook for the industry in Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Meeting with EU Commissioner-Designate Michael McGrath (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Oireachtas members regarding the development of a national strategy for the life sciences sector (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Commissioner-designate Michael McGrath regarding TPLF (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Oireachtas members to promote shared industry priorities ahead of GE 2024 (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Minister of State for Business on life sciences sector priorities (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Meetings with Sinn Féin Spokespersons on life sciences industry priorities in Leinster House (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Representation to Minister of State Neale Richmond on incentives for biopharmaceutical innovation. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Site visit by Minister Simon Coveney to Janssen facility in Cork. (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2023 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Irish policymakers on the proposed EU Product Liability Directive (Legislation) | 2 | On lobbying.ie |
| Sep–Dec 2023 | Janssen Sciences Ireland UC | Economic Development and Industry | Site tour of Visioncare Limerick facility for Oireachtas members (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2022 | Janssen Sciences Ireland UC | Economic Development and Industry | Sharing information on J&J activities in Ireland and discussion of life sciences sectoral strategy for Ireland (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2022 | Janssen Sciences Ireland UC | Economic Development and Industry | Discussion on Transposition of EU Representative Actions Directive (EU-RAD) in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2022 | Janssen Sciences Ireland UC | Economic Development and Industry | Discussion on issues affecting biopharmaceutical and manufacturing technology industries in Ireland including specialised skills and talent, digital strategy, energy policy, healthcare and medicines policy (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2021 | Janssen Sciences Ireland UC | Economic Development and Industry | Discussion with Minister on investment in R&D, STEM talent and skills to enable Ireland to achieve its ambition of becoming an innovation leader. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2021 | Janssen Sciences Ireland UC | Economic Development and Industry | European Innovation Scorecard 2021 with a focus on Ireland’s performance and areas for improvement (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2021 | Janssen Sciences Ireland UC | Economic Development and Industry | Highlighting the importance of apprenticeship training programme for life sciences industry in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2021 | Janssen Sciences Ireland UC | Economic Development and Industry | Discussion on the importance of strong communication between Government and industry, especially in the handling issues such as Brexit and the COVID19 crisis (including the vaccine); importance of new policy… (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2021 | Janssen Sciences Ireland UC | Economic Development and Industry | Highlighted the importance of competitiveness in R&D public investment and improvements in the R&D eco-system (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2021 | Janssen Sciences Ireland UC | Economic Development and Industry | Highlighting the importance of STEM education & apprenticeship training for pharmaceutical industry in Ireland as well as need for continued investment in local infrastructure (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2020 | Janssen Sciences Ireland UC | Economic Development and Industry | Highlighting the importance of STEM education & apprenticeship training for pharmaceutical industry in Ireland as well as need for continued investment in local infrastructure (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2020 | Janssen Sciences Ireland UC | Economic Development and Industry | Briefing on business continuity plans during COVID-19 pandemic and progress on vaccine development as well as offering to support health service with expertise and capabilities (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2019 | Janssen Sciences Ireland UC | Economic Development and Industry | Meeting to discuss operations of J&J in Ireland; EU Digital Health agenda; initiatives increase female participation in STEM-related careers; and implications of Brexit (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2019 | Janssen Sciences Ireland UC | Economic Development and Industry | Sharing overview of life sciences industry and Johnson and Johnson activities in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2019 | Janssen Sciences Ireland UC | Economic Development and Industry | Event Invite (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2018 | Janssen Sciences Ireland UC | Economic Development and Industry | Visit to JSI BIOCorK2 project site (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2018 | Janssen Sciences Ireland UC | Economic Development and Industry | Impact of Brexit on the Life Sciences Sector (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2018 | Janssen Sciences Ireland UC | Economic Development and Industry | Impact of Brexit (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2017 | Janssen Sciences Ireland UC | Economic Development and Industry | Companies (Accounting) Bill 2016 section 3(1)(j) (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2017 | Janssen Sciences Ireland UC | Economic Development and Industry | Companies (Accounting) Bill 2016 section 3(1)(j) (Legislation) | 3 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Economic Development and Industry | 46 | 100.0% |